Position in NTLA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$9,360,164
+$7,624,861 QoQ
Shares Held
730,122
+278.3% QoQ
Ownership
0.523%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Derivatives in NTLA
reported options exposure · as of Mar 31, 2026CallValue
$517,928
CallShares
40,400
PutValue
$334,602
PutShares
26,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026CAPITAL FUND MANAGEMENT S.A. holds $292,594,996 across 34 Biotechnology names. NTLA ranks #10 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
122,934 | $54,894,948 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
140,109 | $46,357,864 | |
| 3 | INCY |
Incyte Corp
|
312,021 | $29,367,416 | |
| 4 | MRNA |
Moderna, Inc.
|
569,930 | $28,952,444 | |
| 5 | EXEL |
Exelixis, Inc.
|
479,693 | $20,574,032 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
174,378 | $11,270,050 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
142,201 | $10,677,873 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
181,065 | $10,228,361 |
All Filings in NTLA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $334,602 | 26,100 | Put | Sole | 2026-05-14 | |
| 2026-03-31 | $517,928 | 40,400 | Call | Sole | 2026-05-14 | |
| 2026-03-31 | $9,360,164 | 730,122 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,735,303 | 193,026 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,815,980 | 202,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $3,288,173 | 190,398 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $3,205,312 | 185,600 | Call | Sole | 2025-11-13 | |
| 2025-09-30 | $611,358 | 35,400 | Put | Sole | 2025-11-13 | |
| 2025-06-30 | $3,485,673 | 371,607 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $2,520,406 | 268,700 | Call | Sole | 2025-08-13 | |
| 2025-06-30 | $783,230 | 83,500 | Put | Sole | 2025-08-13 | |
| 2025-03-31 | $968,765 | 136,254 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $1,166,751 | 164,100 | Call | Sole | 2025-05-14 | |
| 2024-12-31 | $514,206 | 44,100 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $384,387 | 18,705 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $369,270 | 16,500 | Put | Sole | 2024-08-13 | |
| 2024-06-30 | $984,720 | 44,000 | Call | Sole | 2024-08-13 | |
| 2024-03-31 | $2,305,338 | 83,800 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $2,671,221 | 97,100 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $2,546,820 | 92,578 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,695,388 | 121,200 | Put | Sole | 2024-02-14 | |
| 2023-12-31 | $2,359,926 | 77,400 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $1,283,772 | 40,600 | Put | Sole | 2023-11-14 | |
| 2023-09-30 | $784,176 | 24,800 | Call | Sole | 2023-11-14 | |
| 2023-03-31 | $4,012,339 | 107,656 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,834,027 | 109,889 | Shares | Sole | 2023-02-13 | |
| 2021-03-31 | $938,983 | 11,700 | Put | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||